دورية أكاديمية
123I metaiodobenzylguanidine (MIBG) scintigraphy of retinoblastoma: preliminary experience.
| العنوان: | 123I metaiodobenzylguanidine (MIBG) scintigraphy of retinoblastoma: preliminary experience. |
|---|---|
| المؤلفون: | Bomanji, J, Hungerford, J L, Kingston, J E, Levison, D A, Britton, K E |
| بيانات النشر: | BMJ Publishing Group Ltd |
| سنة النشر: | 1989 |
| المجموعة: | HighWire Press (Stanford University) |
| مصطلحات موضوعية: | Research Article |
| الوصف: | 123I metaiodobenzylguanidine (MIBG) is a radiopharmaceutical used for imaging neural crest tumours. The possibility of using 123I MIBG for imaging retinoblastomas has been assessed in this pilot study. Ten patients were studied, nine with clinically and histologically proved retinoblastomas and one with Coats's disease. 123I MIBG scintigraphy correctly identified the neoplasm in eight patients but gave a negative result in two, one of whom had Coats's disease and the other a retinoblastoma which proved to be extensively necrotic on histological examination. These preliminary results suggest that 123I MIBG scintigraphy may have a role in differentiating retinoblastomas from lesions that simulate them. |
| نوع الوثيقة: | text |
| وصف الملف: | text/html |
| اللغة: | English |
| العلاقة: | http://bjo.bmj.com/cgi/content/short/73/2/146Test; http://dx.doi.org/10.1136/bjo.73.2.146Test |
| DOI: | 10.1136/bjo.73.2.146 |
| الإتاحة: | https://doi.org/10.1136/bjo.73.2.146Test http://bjo.bmj.com/cgi/content/short/73/2/146Test |
| حقوق: | Copyright (C) 1989, BMJ Publishing Group Ltd |
| رقم الانضمام: | edsbas.DAAB2800 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1136/bjo.73.2.146 |
|---|